The Arab Drug Company (EGX:ADCI)

Egypt · Delayed Price · Currency is EGP

216.00

+4.85 (2.30%)

At close: Jun 4, 2026

Revenue by Segment

Financials in millions EGP. Fiscal year is July - June.

Millions EGP. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017	Jun '16 Jun 30, 2016
Pharmaceuticals	1.12B	785.52M	633.73M	505.04M	537.05M
Pharmaceuticals Growth	42.35%	23.95%	25.48%	-5.96%	3.12%
Total	1.12B	785.52M	633.73M	505.04M	537.05M
Total Growth	42.35%	23.95%	25.48%	-5.96%	3.12%

Revenue by Geography

Financials in millions EGP. Fiscal year is July - June.

Millions EGP. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017	Jun '16 Jun 30, 2016
Egypt	1.12B	785.52M	633.73M	505.04M	537.05M
Egypt Growth	42.35%	23.95%	25.48%	-5.96%	3.12%
Total	1.12B	785.52M	633.73M	505.04M	537.05M
Total Growth	42.35%	23.95%	25.48%	-5.96%	3.12%

Source: S&P Global Market Intelligence.